Clinical trial
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma: a Prospective Umbrella Clinical Study
NCT06255210 is registered in ClinicalTrials.gov with Hongmeng Yu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma: a Prospective Umbrella Clinical Study
- Lead sponsor
- Hongmeng Yu
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- March 1, 2024
- Completion date
- March 1, 2030
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
olfactory neuroblastoma